Aipalolitovorelizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aipalolitovorelizumab, covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment [Phase 2]